Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Diphosphate, Primaquine
2. Phosphate, Primaquine
3. Primacin
4. Primaquine
5. Primaquine Diphosphate
1. Primaquine Diphosphate
2. 63-45-6
3. Primaquine Bisphosphate
4. Primaquine (diphosphate)
5. Malquine
6. 1,4-pentanediamine, N4-(6-methoxy-8-quinolinyl)-, Phosphate (1:2)
7. Primaquine Phosphate;primaquine Bisphosphate
8. N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine Bis(phosphate)
9. H0982hf78b
10. Nsc-149765
11. N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine; Bis(phosphoric Acid)
12. Primaquine Bis(phosphate)
13. Wr 2975
14. Dsstox_cid_25248
15. Dsstox_rid_80773
16. Dsstox_gsid_45248
17. Ccris 1946
18. Sr-05000001864
19. Ncgc00178754-06
20. Einecs 200-560-8
21. Nsc 149765
22. Primaquine Phosphate [usp]
23. Unii-h0982hf78b
24. Primaquine (tn)
25. Prestwick_406
26. Primaquini Diphosphas
27. Camden
28. Sn13272 Diphosphate
29. 8-((4-amino-1-methylbutyl)amino)-6-methoxyquinoline Diphosphate
30. Cas-63-45-6
31. Ncgc00016284-01
32. 8-((4-amino-1-methylbutyl)amino)-6-methoxyquinoline Phosphate (1:2)
33. Primachine Phosphate
34. Schembl41096
35. Chembl43128
36. Primaquine Bisphosphate, 98%
37. Spectrum1500500
38. Dtxsid6045248
39. Hms502i08
40. Primaquine Phosphate (jan/usp)
41. 8-(4-amino-1-methylbutylamino)-6-methoxyquinoline Diphosphate
42. 8-(4-amino-1-methylbutylamino)-6-methoxyquinolinediphosphate
43. Hms1569o14
44. Hms1920j18
45. Hms2092a19
46. Hms2096o14
47. Hms3652b19
48. Hms3713o14
49. Primaquine Phosphate [jan]
50. Primaquine Diphosphate [mi]
51. Ibscreen-bb Bb_sc-03079
52. Primaquine Phosphate [vandf]
53. Tox21_110350
54. Ccg-40283
55. Mfcd00013166
56. Primaquine Phosphate [mart.]
57. S4237
58. Primaquine Phosphate [usp-rs]
59. Primaquine Phosphate [who-dd]
60. (+-)-8-((4-amino-1-methylbutyl)amino)-6-methoxyquinoline Phosphate (1:2)
61. 1,4-pentanediamine, N(sup 4)-(6-methoxy-8-quinolinyl)-, Phosphate (1:2)
62. Akos026749962
63. Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-, Phosphate (1:2)
64. Tox21_110350_1
65. Cs-3875
66. Primaquine Diphosphate [who-ip]
67. 1,4-pentanediamine, N(sup 4)-(6-methoxy-8-quinolinyl)-, (+-)-, Phosphate (1:2)
68. Ncgc00094767-01
69. Ncgc00094767-02
70. As-13148
71. Hy-12651
72. Primaquine Phosphate [orange Book]
73. Db-054488
74. Primaquine Phosphate [usp Monograph]
75. Primaquine Diphosphate [ep Monograph]
76. Primaquini Diphosphas [who-ip Latin]
77. Sw196647-3
78. D02126
79. E75742
80. 013p166
81. Sr-05000001864-1
82. Sr-05000001864-3
83. Sr-05000001864-7
84. Q27279400
85. N4-(6-methoxyquinolin-8-yl)pentane-1,4-diaminebis(phosphate)
86. 8-(4-amino-1-methylbutylamino)-6-methoxyquinoline Diphosphate Salt
87. 1,4-pentanediamine, N^4-(6-methoxy-8-quinolinyl)-, Phosphate (1:2)
88. 8-?(4-?amino-?1-?methylbutylamino)?-?6-?methoxyquinoline Diphosphate Salt
89. Primaquine Diphosphate, European Pharmacopoeia (ep) Reference Standard
90. Primaquine Phosphate, United States Pharmacopeia (usp) Reference Standard
91. Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-, Diphosphate
Molecular Weight | 455.34 g/mol |
---|---|
Molecular Formula | C15H27N3O9P2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 6 |
Exact Mass | 455.12225344 g/mol |
Monoisotopic Mass | 455.12225344 g/mol |
Topological Polar Surface Area | 216 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 312 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Primaquine phosphate |
Drug Label | Primaquine phosphate is 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline phosphate, a synthetic compound with potent antimalarial activity. Each tablet contains 26.3 mg of Primaquine phosphate (equivalent to 15 mg of primaquine base). The dosage i... |
Active Ingredient | Primaquine phosphate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 15mg base |
Market Status | Prescription |
Company | Bayshore Pharms; Alvogen |
2 of 2 | |
---|---|
Drug Name | Primaquine phosphate |
Drug Label | Primaquine phosphate is 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline phosphate, a synthetic compound with potent antimalarial activity. Each tablet contains 26.3 mg of Primaquine phosphate (equivalent to 15 mg of primaquine base). The dosage i... |
Active Ingredient | Primaquine phosphate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 15mg base |
Market Status | Prescription |
Company | Bayshore Pharms; Alvogen |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Primaquine Diphosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Primaquine Diphosphate, including repackagers and relabelers. The FDA regulates Primaquine Diphosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Primaquine Diphosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Primaquine Diphosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Primaquine Diphosphate supplier is an individual or a company that provides Primaquine Diphosphate active pharmaceutical ingredient (API) or Primaquine Diphosphate finished formulations upon request. The Primaquine Diphosphate suppliers may include Primaquine Diphosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Primaquine Diphosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Primaquine Diphosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Primaquine Diphosphate active pharmaceutical ingredient (API) in detail. Different forms of Primaquine Diphosphate DMFs exist exist since differing nations have different regulations, such as Primaquine Diphosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Primaquine Diphosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Primaquine Diphosphate USDMF includes data on Primaquine Diphosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Primaquine Diphosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Primaquine Diphosphate suppliers with USDMF on PharmaCompass.
A Primaquine Diphosphate CEP of the European Pharmacopoeia monograph is often referred to as a Primaquine Diphosphate Certificate of Suitability (COS). The purpose of a Primaquine Diphosphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Primaquine Diphosphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Primaquine Diphosphate to their clients by showing that a Primaquine Diphosphate CEP has been issued for it. The manufacturer submits a Primaquine Diphosphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Primaquine Diphosphate CEP holder for the record. Additionally, the data presented in the Primaquine Diphosphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Primaquine Diphosphate DMF.
A Primaquine Diphosphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Primaquine Diphosphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Primaquine Diphosphate suppliers with CEP (COS) on PharmaCompass.
A Primaquine Diphosphate written confirmation (Primaquine Diphosphate WC) is an official document issued by a regulatory agency to a Primaquine Diphosphate manufacturer, verifying that the manufacturing facility of a Primaquine Diphosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Primaquine Diphosphate APIs or Primaquine Diphosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Primaquine Diphosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Primaquine Diphosphate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Primaquine Diphosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Primaquine Diphosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Primaquine Diphosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Primaquine Diphosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Primaquine Diphosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Primaquine Diphosphate suppliers with NDC on PharmaCompass.
Primaquine Diphosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Primaquine Diphosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Primaquine Diphosphate GMP manufacturer or Primaquine Diphosphate GMP API supplier for your needs.
A Primaquine Diphosphate CoA (Certificate of Analysis) is a formal document that attests to Primaquine Diphosphate's compliance with Primaquine Diphosphate specifications and serves as a tool for batch-level quality control.
Primaquine Diphosphate CoA mostly includes findings from lab analyses of a specific batch. For each Primaquine Diphosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Primaquine Diphosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Primaquine Diphosphate EP), Primaquine Diphosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Primaquine Diphosphate USP).
LOOKING FOR A SUPPLIER?